줄기세포 치료 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 유형별, 세포원별, 용도별, 최종사용자별, 지역별 부문, 경쟁(2020-2030년)
Stem Cell Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Cell Source, By Application, By End User, By Region and Competition, 2020-2030F
상품코드:1796843
리서치사:TechSci Research
발행일:2025년 08월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
줄기세포 치료 세계 시장은 2024년에 3억 6,854만 달러로 평가되었고, 예측 기간 중 연평균 복합 성장률(CAGR)은 13.06%로, 2030년에는 7억 6,987만 달러에 이를 것으로 예측됩니다.
줄기세포 치료는 재생의료라고도 불리며, 줄기세포와 그 유도체를 이용하여 질병이나 기능부전, 손상된 조직의 회복 반응을 촉진하는 치료법입니다. 재생의료는 장기 이식의 다음 단계로서, 사용 가능한 장기가 한정된 기증자의 장기를 세포로 대체하는 것입니다. 줄기세포는 인체 내에서 다양한 세포로 분화할 수 있는 능력을 가지고 있으며, 회복 메커니즘으로 작용합니다. 줄기세포는 배아줄기세포와 성체줄기세포의 두 가지 주요 분류가 있습니다. 줄기세포는 크게 다능성 줄기세포와 유도만능줄기세포로 나뉩니다. 배아나 태아의 조직에서 만들어져 복제를 거쳐 중배엽, 외배엽, 내배엽의 세 가지 생식세포층 내 세포와 조직의 발달에 기여하는 만능줄기세포. 예를 들어, 2020년 1월, 마이애미 대학 연구진은 폐 손상을 입은 코로나19 환자에게 줄기세포를 두 번 주입했습니다. 그 결과, 심각한 부작용은 없었고, 치료는 신뢰할 수 있는 것으로 결론지었습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
3억 6,854만 달러
시장 규모 : 2030년
7억 6,987만 달러
CAGR : 2025년-2030년
13.06%
급성장 부문
동종 이식
최대 시장
북미
시장 성장 촉진요인
줄기세포 치료의 기술 발전 증가
주요 시장 이슈
고비용 치료
주요 시장 동향
임상시험 및 연구 증가
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 줄기세포 치료 시장 전망
시장 규모와 예측
금액별
시장 점유율과 예측
유형별(동종 이식, 자가 이식)
세포원별(지방조직 유래 중간엽줄기세포, 골수 유래 중간엽줄기세포, 제대혈/배성줄기세포)
용도별(암, 근골격 장애, 창상, 심혈관질환, 기타)
최종사용자별(병원, 외과 센터, 치료 회사)
지역별
기업별(2024년)
시장 맵
제6장 북미의 줄기세포 치료 시장 전망
시장 규모와 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 줄기세포 치료 시장 전망
시장 규모와 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
영국
이탈리아
프랑스
스페인
제8장 아시아태평양의 줄기세포 치료 시장 전망
시장 규모와 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 남미의 줄기세포 치료 시장 전망
시장 규모와 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 줄기세포 치료 시장 전망
시장 규모와 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
남아프리카공화국
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
제13장 세계의 줄기세포 치료 시장 : SWOT 분석
제14장 경쟁 구도
Biorestorative Therapies Inc.
Celgene corporation
ReNeuron Group plc
Opexa Therapeutics, Inc.
Pluristem Therapeutics Inc
STEMCELL Technologies Inc.
Biovault family
Precious Cells International Ltd
Mesoblast Ltd
Seneca Biopharmaceuticals, Inc.
제15장 전략적 제안
제16장 회사 소개 및 면책조항
LSH
영문 목차
영문목차
Global Stem Cell Therapy Market was valued at USD 368.54 Million in 2024 and is expected to reach USD 769.87 Million by 2030 with a CAGR of 13.06% during the forecast period. Stem cell therapy, also referred to as regenerative medicine, facilitates the repair response of diseased, dysfunctional, or injured tissue through the utilization of stem cells or their derivatives. It represents the subsequent phase in organ transplantation, substituting donor organs-which are limited in availability-with cells. Stem cells possess the capability to differentiate into various cell types within the human body, functioning as a restorative mechanism. There exist two primary classifications of stem cells: embryonic stem cells and adult stem cells. Stem cells are further categorized into two major groups: pluripotent and multipotent. Pluripotent stem cells, derived from embryos or fetal tissues, undergo replication and contribute to the development of cells and tissues within the mesoderm, ectoderm, and endoderm-the three primary germ layers. For instance, in January 2020, researchers from the University of Miami administered two stem cells infusions to COVID-19 patients that were suffering from lung damage. The results concluded that there were no significant side effects, and the therapy was reliable.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 368.54 Million
Market Size 2030
USD 769.87 Million
CAGR 2025-2030
13.06%
Fastest Growing Segment
Allogenic Transplants
Largest Market
North America
Key Market Drivers
Increasing Technological Advancement in Stem Cell Therapeutics
The progress of stem cell therapies has been facilitated by advancements in stem cell isolation, expansion, and differentiation techniques. Scientists are currently investigating different sources of stem cells, such as embryonic stem cells, induced pluripotent stem cells (iPSCs), and adult stem cells. Furthermore, emerging technologies like gene editing (e.g., CRISPR) hold promise for improving the precision and effectiveness of stem cell-based treatments. The constant awareness and availability of stem cell therapies have triggered an increasing demand for innovation and system development. Market players are actively seeking collaborations to enhance their research and development activities, aiming to expand the stem cell treatment market in both developing and developed nations. Substantial funding has been invested in cell-based research, particularly in the field of induced pluripotent stem cells. This technique involves genetic reprogramming of adult human stem cells to obtain embryonic-like stem cells, serving as a viable alternative in the market.
Key Market Challenges
High-Cost Treatment
Developing and implementing stem cell therapies involves significant research, clinical trials, and manufacturing costs. The high costs associated with research, development, and production can limit accessibility for patients. The expansion of the cell treatment market has been hindered by its high cost. As individuals seek out the latest therapeutic options, cell treatments have gained popularity as a treatment choice. Despite the significant increase in demand, cell treatments remain prohibitively expensive. Joint injections alone can cost up to $1,000, while more complex procedures may reach up to $100,000. In the United States, the average cost of stem cell therapy is projected to range between $4,000 and $8,000 per patient in 2020. Consequently, the growth of the stem cell therapy market is constrained by the elevated cost of treatment.
Key Market Trends
Increased Clinical Trials and Research
The field of stem cell therapy is likely to see continued growth in clinical trials and research studies. As scientists better understand stem cell behavior and optimize their use, more evidence will be generated to support their efficacy and safety for various medical conditions. Ongoing research will likely reveal new and diverse applications for stem cell therapy across various medical conditions. As the understanding of stem cells expands, scientists may identify previously unrecognized opportunities for treatment.
Key Market Players
Biorestorative Therapies Inc.
Celgene corporation
ReNeuron Group plc
Opexa Therapeutics, Inc.
Pluristem Therapeutics Inc
STEMCELL Technologies Inc.
Biovault family
Precious Cells International Ltd
Mesoblast Ltd
Seneca Biopharmaceuticals, Inc.
Report Scope:
In this report, the Global Stem Cell Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Stem Cell Therapy Market, By Type:
Allogenic Transplants
Autologous Transplants
Stem Cell Therapy Market, By Cell Source:
Adipose Tissue-Derived Mesenchymal Stem Cells
Bone Marrow-Derived Mesenchymal Stem Cells
Cord Blood/Embryonic Stem Cells
Stem Cell Therapy Market, By Application:
Cancer
Musculoskeletal Disorder
Wounds and Injuries
Cardiovascular Disease
Others
Stem Cell Therapy Market, By End User:
Hospitals and Surgical Centres
Therapeutic Companies
Stem Cell Therapy Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Stem Cell Therapy Market.
Available Customizations:
Global Stem Cell Therapy market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Service Overview
2. Research Methodology
3. Executive Summary
4. Voice of Customer
5. Global Stem Cell Therapy Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Allogenic Transplants, Autologous Transplants)
5.2.2. By Cell Source (Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells)
5.2.3. By Application (Cancer, Musculoskeletal Disorder, Wounds and Injuries, Cardiovascular Disease, Others)
5.2.4. By End User (Hospitals and Surgical Centres, Therapeutic Companies)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Stem Cell Therapy Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Cell Source
6.2.3. By Application
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Stem Cell Therapy Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Cell Source
6.3.1.2.3. By Application
6.3.1.2.4. By End User
6.3.2. Canada Stem Cell Therapy Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Cell Source
6.3.2.2.3. By Application
6.3.2.2.4. By End User
6.3.3. Mexico Stem Cell Therapy Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Cell Source
6.3.3.2.3. By Application
6.3.3.2.4. By End User
7. Europe Stem Cell Therapy Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Cell Source
7.2.3. By Application
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Stem Cell Therapy Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Cell Source
7.3.1.2.3. By Application
7.3.1.2.4. By End User
7.3.2. United Kingdom Stem Cell Therapy Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Cell Source
7.3.2.2.3. By Application
7.3.2.2.4. By End User
7.3.3. Italy Stem Cell Therapy Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Cell Source
7.3.3.2.3. By Application
7.3.3.2.4. By End User
7.3.4. France Stem Cell Therapy Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Cell Source
7.3.4.2.3. By Application
7.3.4.2.4. By End User
7.3.5. Spain Stem Cell Therapy Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Cell Source
7.3.5.2.3. By Application
7.3.5.2.4. By End User
8. Asia-Pacific Stem Cell Therapy Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Cell Source
8.2.3. By Application
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Stem Cell Therapy Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Cell Source
8.3.1.2.3. By Application
8.3.1.2.4. By End User
8.3.2. India Stem Cell Therapy Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Cell Source
8.3.2.2.3. By Application
8.3.2.2.4. By End User
8.3.3. Japan Stem Cell Therapy Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Cell Source
8.3.3.2.3. By Application
8.3.3.2.4. By End User
8.3.4. South Korea Stem Cell Therapy Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Cell Source
8.3.4.2.3. By Application
8.3.4.2.4. By End User
8.3.5. Australia Stem Cell Therapy Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Cell Source
8.3.5.2.3. By Application
8.3.5.2.4. By End User
9. South America Stem Cell Therapy Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Application
9.2.3. By Cell Source
9.2.4. By End User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Stem Cell Therapy Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Cell Source
9.3.1.2.3. By Application
9.3.1.2.4. By End User
9.3.2. Argentina Stem Cell Therapy Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Cell Source
9.3.2.2.3. By Application
9.3.2.2.4. By End User
9.3.3. Colombia Stem Cell Therapy Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Cell Source
9.3.3.2.3. By Application
9.3.3.2.4. By End User
10. Middle East and Africa Stem Cell Therapy Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Cell Source
10.2.3. By Application
10.2.4. By End User
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Stem Cell Therapy Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Cell Source
10.3.1.2.3. By Application
10.3.1.2.4. By End User
10.3.2. Saudi Arabia Stem Cell Therapy Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Cell Source
10.3.2.2.3. By Application
10.3.2.2.4. By End User
10.3.3. UAE Stem Cell Therapy Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Cell Source
10.3.3.2.3. By Application
10.3.3.2.4. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
13. Global Stem Cell Therapy Market: SWOT Analysis
